Novel cellular therapies for hepatobiliary malignancies.
Xue JN, Wang YY, Wang YC, Zhang N, Zhang LH, Lu ZH, Zhao LJ, Zhao HT.
Xue JN, et al.
Hepatobiliary Pancreat Dis Int. 2022 Oct;21(5):450-454. doi: 10.1016/j.hbpd.2022.08.014. Epub 2022 Sep 6.
Hepatobiliary Pancreat Dis Int. 2022.
PMID: 36100543
Review.